Incidence and Survival of Testicular Cancers in a Province in Northern Italy and Their Association with Second Tumors

Author:

Mangone Lucia1ORCID,Marinelli Francesco1ORCID,Bisceglia Isabella1ORCID,Masini Cristina2,Palicelli Andrea3ORCID,Morabito Fortunato4ORCID,Di Girolamo Stefania2ORCID,Neri Antonino5,Pinto Carmine2ORCID

Affiliation:

1. Epidemiology Unit, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy

2. Medical Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy

3. Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy

4. Biotechnology Research Unit, AO di Cosenza, 87100 Aprigliano, Italy

5. Scientific Directorate, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy

Abstract

This study investigated the incidence, mortality, and 5-year survival rates of testicular cancers diagnosed in a northern Italian province, which were eventually associated with previous or subsequent extratesticular neoplasms. Cases from 1996 to 2020 were examined by age and histotype (seminoma vs. non-seminoma). The standardized incidence rate was calculated using the European population, and the annual percent change (APC) was reported. The five-year relative survival was estimated using the Pohar Perme method. The association with the second neoplasm was also evaluated. In our study, 385 patients with testicular cancer were included, most of whom were aged between 30 and 40 years. The non-seminoma and seminoma groups accounted for 44% and 18% of younger adults, respectively. The incidence rate increased during the study period (APC 1.6*); however, it increased in seminomas (APC 2.3*) but not in non-seminomas (APC −0.1). Conversely, the mortality rate remained constantly low either overall or in each of the two groups. The overall 5-year survival rate of testicular cancer patients was 95% (99% and 88% for seminomas and non-seminomas, respectively). Primary extratesticular tumors were documented in 37 cases, 18 after and 19 before the testicular cancer diagnosis. Our study confirms that the increased incidence and excellent survival rate are the prerogative of seminomas.

Funder

Italian Ministry of Health—Ricerca Corrente Annual Program

Publisher

MDPI AG

Subject

General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology

Reference35 articles.

1. Rajpert-De Meyts, E., Skakkebaek, N.E., and Toppari, J. (2018). Testicular Cancer Pathogenesis, Diagnosis and Endocrine Aspects, MDText.com, Inc.

2. Testicular cancer;Cheng;Nat. Rev. Dis. Prim.,2018

3. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): A population-based, cohort study;Bright;Lancet Oncol.,2019

4. Eble, J.N., Sauter, G., Epstein, J.I., and Sesterhenn, I.A. (2004). World Health Organization: Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs, IARC Press.

5. (2023, September 20). Available online: https://www.cancer.org/cancer/testicular-cancer/about/key-statistics.html.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3